Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura - Hie, M; Gay, J; Galicier, L (Blood, 2014)
, et al; French Thrombotic Microangiopathies Reference Centre.